Blockchain Registration Transaction Record

LakeShore Biopharma Calls EGM to Vote on Going Private Merger

LakeShore Biopharma (OTCPK: LSBCF) calls EGM on June 19, 2026 to vote on merger with Oceanpine Skyline Inc., taking the company private. Shareholders urged to vote on delisting and deregistration.

This merger matters because it will take LakeShore Biopharma private, removing its shares from public trading and altering shareholder liquidity. The decision reflects a trend of biotech companies seeking private ownership to focus on R&D without quarterly earnings pressure. For investors, it means potential exit at the merger price, but loss of public market access. The move could accelerate the company's vaccine development, particularly its PIKA® platform, impacting global health by potentially speeding up treatments for Rabies, Hepatitis B, and cancer.